RecruitingPhase 1NCT07429448

Comparison Of Clinical Outcomes of Intraperitoneal Bupivacaine Instillation Versus Placebo as Preemptive Analgesia in Patients Undergoing Open Appendectomy


Sponsor

Sardar Umer Rehman

Enrollment

60 participants

Start Date

Dec 16, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

To compare the clinical outcomes of intraperitoneal bupivacaine instillation vs placebo as preemptive analgesia in patients undergoing open appendectomy


Eligibility

Min Age: 20 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Bupivacain and Normal Saline for people with appendectomy. The study is currently recruiting participants at 1 location. People eligible for this study include aged 20 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGBupivacain

Bupivacaine with 0.25% of concentration at the end of the operation intraperitoneally.

OTHERNormal Saline

10ml of Normal Saline at the end of the operation intraperitoneally.


Locations(1)

Services Institute of Medical Sciences/ Services Hospital Lahore

Lahore, Punjab Province, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07429448


Related Trials